NBT Bank N A NY Buys 744 Shares of Stryker Corporation (NYSE:SYK)

NBT Bank N A NY boosted its position in Stryker Corporation (NYSE:SYK - Free Report) by 17.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,984 shares of the medical technology company's stock after acquiring an additional 744 shares during the quarter. NBT Bank N A NY's holdings in Stryker were worth $1,855,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Kohmann Bosshard Financial Services LLC purchased a new stake in Stryker in the fourth quarter worth $25,000. Capital A Wealth Management LLC bought a new stake in Stryker during the fourth quarter valued at approximately $26,000. Rakuten Securities Inc. grew its holdings in Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares during the period. Centricity Wealth Management LLC purchased a new position in Stryker during the fourth quarter valued at approximately $30,000. Finally, BankPlus Trust Department bought a new stake in Stryker during the fourth quarter valued at about $33,000. Institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on SYK shares. Truist Financial increased their target price on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research report on Monday, May 5th. Citigroup reaffirmed a "buy" rating and set a $455.00 price objective (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Roth Mkm lifted their price objective on shares of Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research report on Friday, May 2nd. The Goldman Sachs Group set a $422.00 target price on shares of Stryker in a research report on Tuesday, March 4th. Finally, BTIG Research set a $403.00 price target on shares of Stryker and gave the company a "buy" rating in a report on Monday, April 14th. Four equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Stryker currently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Price Performance

SYK stock opened at $373.36 on Wednesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. The business's 50-day moving average is $373.73 and its two-hundred day moving average is $375.54. The firm has a market capitalization of $142.51 billion, a P/E ratio of 50.45, a P/E/G ratio of 2.84 and a beta of 0.91. Stryker Corporation has a 1 year low of $314.93 and a 1 year high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. During the same quarter last year, the company posted $2.50 earnings per share. The business's quarterly revenue was up 11.9% compared to the same quarter last year. Analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.90%. Stryker's payout ratio is currently 45.41%.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This represents a 5.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 5.20% of the stock is owned by corporate insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.